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SUMMARY 
Male outbred jirds (Merione~ uniuiculatus) were innoculated 
with doses of 100 or 200 infective Brugia pahangi larvae (1 3
1 s), 
and tested for complement fixing circulating antibody. Following 
innoculation, all test animals became positive for microfilaria 
in peripheral blood. Seventeen of 20 test animals develop~d 
patent, sustained infections within, or shortly after 60 days. 
The longest prepotent period was measured at 118 days. Readings 
of microfilarial densities were taken after the first month, 
through 12 months, with the final microfilarial reading between 
12 and 21 months. Microfilarial densities vacillated through 
the course of infection. 
At the time of necropsy, adult worms were recovere recovered 
from the testes, heart and pulmonary regions, pelt and carcass 
and viscera. Recovered adults were sexed and counted for their 
particular region of residence. The majority of the recovered 
adults were found in either the testicular region or the pul-
monary region with small percentages in other areas. Total 
worm recovery was between 25% and 30% of the 1 3 dosage innocu-
lated. 
Complement fixation reagent concentrations; Rabbit Hemo-
lys.in, Guinea Pig Complement, and !?_. pahangi antigen were titrated 
and standardized (HEW Technical Report, 1965). Complement fixa-
tion tests were performed with test sera from infected animals 
divided into 2 groups (A & B), Group A animals had consistently 
low microfilarial densities throughout the course of infection 
(<500) with Group B maintaining high densities throughout (>500). 
The lowest positive titer was determined at 1:4 with the highest 
titer observed at 1:256. Animals of Group A were demonstrated 
at having significantly greater mean antibody titers during the 
third, sixth and post twelve month periods with relation to Group 
B. The complement fixation titers showed a correlation beLween 
microfilarial densities and mean antibody titers, between the 
two test groups, at significant time periods. 
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( 1 ) 
Several hundred species of nematodes belonging to the Order 
Filariidea are known to be parasitic in the tissues of various 
vertebrate hosts, with several species being disease causing 
agents in man (Sasa, 1976). The species which can infect humans 
are: Wuchereria bancrofti, Brugia malayi, ~. pahangi, Loa loa, 
Dipetalonema perstans, Q. streptocerca, Mansonella ozzardi, and 
Onchocerca volvulaso The World Health Organization indicated 
that at least 250 million people were infected with the lymphatic-
dwelling filaria, W. bancrofti and B. malayi (WHO Technical Re-
port, 1974). The taxonomic status of these two closely related 
species has been fully described in literature, (Lichtenstien, 
1927; Burg, 1927; Rao and Maplestone, 1940; Buckley and Edeson, 
1956; and Buckley, 1960). 
"~. bancrofti infection in humans has been recorded in nearly 
all countries or territories in the tropical and subtropical zones 
of the world, with the exceptions of the deserts or very dry areas. 
The disease has also been noted from some temperate zone districts 
such as the mainland of Japan, middle China, and some European 
countries. Major endemic areas include the South Pacific, South 
East Asia, South and Central America, and Africa". (Sasa, 1976) 
Bancroftian filariasis was reported in Charleston, N.C. and through 
some of the Southern United States in the 1800's until approximately 
1920. The disease disappeared spontaniously before World War II 
due to improvements in general sanitary conditions and the reduction 
of its disease vector, Culex pipiens. 
Malayan filariasis is endemic exclusively in South and East Asia 
(2) 
Major endemic regions include: India, Burma, Thailand, Vietnam, the 
Philippines, Malayia, Indonesia, Southern Japan, China, and Korea. 
The spread of malayan filariasis has been apparently barricaded to 
the North and West by the desert zone extending from West Pakistan 
to Mongolia. Temperature is probably another factor that has 
restricted its distribution northwards and beyond the Southern re-
gions of Japan, Korea, and China (Sasa, 1976). 
B. pahangi is principally a lymphatic-dwelling parasite in car-
nivores, with a limited range in primate hosts and man. Differen-
tial diagnosis of~. malayi and~. pahangi in humans can be rather 
difficult with both species existing simultaniously in the same host 
(Denham and McGreevy, 1977). B. pahangi is endemic in West Malaysia 
exclusively. 
The adult worms of both Wuchereria and Brugia reside principal-
ly in the lymphatics of man. The female worms produce sheathed 
embryos called microfilaria which appear in circulating blood, 
occasionally showing in hydrocele fluid and chylous urine. The 
microfilaria are ingested by mosquito intermediate hosts, lose 
their sheaths, and burrow through the midgut wall into the body 
cavity, reaching the thoracic muscles within a few hours. They 
develop into mature third-stage larvae after undergoing three morpho-
logical stages. Two days after successful thoracic muscle penetra-
tion, the larvae metamorphose into a short, thick, sausage-like 
form. Developmental differentiation proceeds rapidly, within 5 
to 6 days the second morphogenesis is achieved. At around the 10th 
day of development third stage differentiation begins, resulting in 
(J) 
elongation of the larvae to a long snake-like stage. The mature lar-
vae leave the thoracic muscles, enter the body cavity, and migrate 
to the proboscus. When the mosquito takes a blood meal, the larvae 
enter the primary host through the puncture wound left by the mos-
quito. 
The development of~. malayi third stage larvae to mature adults, 
in human hosts, will take up to a year or longer. The adult worms 
are thread-like and creamy white in appearance with a smooth cuti-
cula. The adult male~. malayi taken from humans measure 13.5 to 
2J.J mm in length and 0.07 to 0.08 mm in width, while mature females 
measure 43.5 mm to 55 mm in length and O.iJ to O.i? mm in width 
(Faust et. al., 197 O) . The adult developmental period for B. 2ahangi 
in the jird (Gerbil) host (Meriones unguiculatus) is 55 to 60 days. 
The adult male B. 2ahangi taken from jirds measure 13.1 mm in length 
and 48 microns in width, while mature females measure 36.J mm in 
length and 77 microns in width (Ash and Riley, 1970). The develop-
ment time for W. bancrofti in the human host varies up to a year or 
more. The adult male worms taken from human autopsies, measure 
about 40 mm in length and 0.1 mm in diameter while mature female worms 
measure 80 to 100 mm in length and 0.24 to O.J mm in diameter (Faust 
e t . al ., 19 7 0 ) • 
Microfilaria Periodicity 
Microfilaria periodicity is defined as the ability of different 
species of microfilaria to react to the availability of its specific 
(4) 
intermediate vector. The result of this periodicity is that the 
microfilaria will have greater densities in peripheral circulating 
blood during the time the specific vector is present in the enviro-
nment. One of the most significant aspects of infraspecific taxonomy 
is the occurence of clearly defined races, each characterized by the 
pattern of their microfilarial periodicity~ Methods for surveys 
and the statistical analysis of' such characteristics have been pre-
viously described by several researchers (Gubler and Bhattacharya, 
1974; Sasa, 1976; Turner and Edeson, 1957). 
"In W. bancrofti, two races differing in microfilarial periodicity 
have been recognized": a nocturnally periodic race distributed widely 
throughout tropical and subtropical zones of the world (with the 
exception of the Polynesian subregion); a nonperiodic, or more pre-
cisely, diurnally subperiodic race reported in a jungle area in West 
Thailand. These races are specific for different vector groups ser-
ving as intermediate hosts. "The microfilarial periodicity of each 
race coincides with the circadian rhythm of the biting activity of 
the principal mosquito vector". (Sasa, 1976) 
In B. malayi, 2 distinct races are known to exist, a nocturnally 
periodic race and a nocturnally subperiodic race, first reported in 
Malaya. The endemic regions are geographically isolated, and each 
uses different mosquito vectors. Both races have been reported from 
a number of areas in Southern and Eastern Asia. ~. pahangi is a 
non-periodic race known to exist concurrently with subperiodic B. 
malayi in the East Pahang Province of Malaya" 
(5) 
Pathology and Symptomatology 
The pathology in humans caused by~. malayi and~. bancrofti is 
similar in many respects with only minor differences. The occur-
rence of acute symptoms such as fever attacks and lymphangitis 
are more frequently encountered in B. malayi infections rather than 
in W. bancrofti. Acute lymphodermia and elephantiasis of the legs, 
hands, and arms are char~cteristic of both, however, involvement in 
the urino-genital organs such as funiculitis, hydrocele, and chyluria, 
are almost exclusive characteristics of W. bancrofti. 
Although shown experimentally transmittable in man (Buckley, 
1958) ~. pahangi fares poorly in the human host. Chronic elephan-
tiasis as seen in~. malayi and W. bancrofti infections is absent 
in~. pahangi infections, however, central nervous system involve-
ment can occur with worms invading the spinal area. Instances of 
this, however, are rare. 
The course of events for Bancroftian and Malayan filariasis can 
be summarized as follows (from Sasa, 1976): 
(A) Subclinical filariasis 
(a.1) The Prepatent Period 
(a.2) Patent phase with microfilaremia 
(B) Clinical filariasis 
(b.1) Recurrent adenolymphangitis 
(b.2) Elephantiasis 
A. Subclinical filariasis 
(a.1) The prepatent period: 
The prepatent period for both diseases refers to the period from 
( 6) 
infection through contact with the intermediate vector to develop-
ment of a microfilaremiao In~. bancrofti infections, this period 
has been estimated to require a year or more following continuous 
exposure of mature infective forms. In Brugia, the prepatent per-
iod in humans has not fully been determined. Experimentally, Edeson 
and Wharton (1958) found this period to be between 76 and 80 days 
in cats. Under natural conditions, the prepatent period is believed 
to be longer due to variqus factors inhibiting mating by adult worms. 
It must be noted, that only after successive exposure to the infec-
tive form larvae through the intermediate mosquito vector, can an 
inf'ectio:n be established under natural conditions. 
(a.2) Patent phase with microfilaremia 
The patent phase is marked by the appearance of microfilaria in 
the circulating blood. With both Wuchereria and Brugia, a consider-
able number of individuals within an endemic population may show 
positive microfilaremias, but are probably symptomless at first, 
Within this population, at least part will exhibit spontaneous re-
mission of microfilaria and continue symptomless, while part will 
remain positive for microfilaria, also remaining symptomless. How-
ever, in heavy endemic areas, many will begin to show acute symptoms 
and later may develop chronic signs. 
(B) Clinical filariasis 
(b.1) The acute stage 
Recurrent episodes of fever with acute inflammation of the super-
ficial lymph nodes and their associated areas are characteristic fea-
tures of filariasis due to Brugia .§.Ql?_. infections (Sasa, 1976). 
(?) 
The first symptoms are a painful tender enlargement of the inguinal 
noctes of one side accompanied by band like streaks of red spreading 
down the limbs in line with the lymphatics. Fever followed by con-
tinued swelling persists for J to 5 days before ending by rapid 
lysis and heavy sweatingo The signs of adenitis and lymphagitis re-
solve gradually during the next 6 to 7 days. Swelling may occur at 
the distal portion of the limb, however, this tends to regress com-
pletely after the episode·. After repeated attacks, the swelling does 
not subside and eventually develops into elephantiasis. 
The acute stage in Bancroftian filariasis is marked by frequent 
fever attacks which are associated with lymphangitis or lymphadentis 
due to inflammation in hypersensitive reactions to the worms and or 
microfilaria. Reactions such as these, usually occur in the legs, 
hands, and urino-genital regions. The fever attacks occur at irre-
gular intervals and become more chronic. As time goes on, permanent 
lesions caused by lymphatic obstructions become more evident. 
(b.2) The chronic stage: 
The chronic stage is marked by the permanent swelling of part of 
the body (elephantiasis). Elephantiasis due to Malayan filariasis 
usually manifests itself in the limbs and hands, rarely in the geni-
tal regions or breasts. The upper extremities are less likely to be 
affected than the legs with this type of filariasis. 
Elephantiasis due to W. bancrofti can involve the limbs and hands, 
but is characterized by urino-genital complications such as hydrocele 
and chyluria. Blockage of the lymphatic areas leads to chronic in-
flammation which in turn is manifested in elephantiasis of an often 
(8) 
incurable nature. 
Treatment with Diethylcarbamazine (DEC): 
Hewitt et. alo (1947) discovered DEC to be a potent filaricide; 
to date it is the chemical treatment of choice. The standard method 
recommended for drug therapy is a dose of 6 mg per kg per person if 
it to be effective as a filaricide. Treatment with DEC, however, 
causes several side effects such as high fever reactions and inflamma-
tion due to precipitating microfilaria, after the initial dose. Due 
to these side effects, treatment campaigns have often failed when 
patient.R refuse to take additional doses of the drug. 
Experimental Work in Filariasis 
Experimental work with filarial infections offers the possibili-
ties of better treatment procedures, control, and the study of host-
parasite relationships. The need for a susceptible small animal host 
had been stressed by the World Health Organization (WHO Technical Re-
port, No. 359» 1967)0 
Infections occuring naturally with W. bancrofti have only been 
demonstrated in man despite intensive surveys of a wide variety of 
feral and domestic animals. Attempts to experimentally infect lab-
oratory animals have either failed or had limited success. Yokogawa 
(1939) found that in suckling mice,~. bancrofti larvae were sur-
rounded by fibroblasts within 15 hours on innoculation. Laing et. 
al. (1961) innoculated JO to 40 infective larvae of periodic~. 
( 9 ) 
bancrofti into 4 cats and 2 Macaca mulatta monkeys, no microfilare-
mias developed during a 15 month period, and no adult worms were 
recovered at necropsy. Dissanaike and Niles (1965) gave 65 larvae 
to a toque monkey and 55 to each of 4 cats. A single third stage 
larvae was recovered from a cat which died 20 days post infection. 
Ramachandran et. al. (1966) innoculated larvae into 15 golden hams-
ters and 2 kittens, recovering only 1 larvae from a kitten at day 
18. In further studies, Ramachandran and Sivanadam (1969) gave in-
creasing larval dosages (40 13 to 170 13 ), to 6 cats, 10 to 37 days 
old, and necropsied them 7 to 27 days later, recovering only 14 lar-
vae. Ash and Schacher (1971) innoculated 60 to 300 infective~. 
bancrofti larvae into each of 74 male jirds (M. unguiculatus). 
Fourth-stage larvae were recovered up to 126 days post innoculation, 
but the fourth molt did not occur and only limited progression was 
seen beyond 6 weeks. Dissanaike and Mak (1968) testicularly innocu-
lated a splenectomized cacaque monkey with 286 infective~. bancrofti 
larvae, and treated with Depomedrol for 6 weeks post innoculation. 
The monkey was necropsied 231 days later recovering 11 mature adult 
worms. Cross eto alo (1979) innoculated infective larvae of W. ban-
crofti in Taiwan monkeys (Macaca cyclopis) through subcutaneous foot 
puncture, or by permitting infected mosquitoes to feed weekly on the 
monkeys. Some animals were splenectomized and others were treated by 
varying regiments of immunosupressants. A total of 78 monkeys were 
exposed to infection with parasites recovered from 63% of the males 
infected and 29% of the females infected. The prepatent period was 
determined to be between 8 and 18 months with patent infections 
(10) 
lasting between 5 and 21 monthso Successful experimental transmission 
of~. bancrofti from patent monkeys to uninfected monkeys was also 
demonstrated. 
Experimental transmission of both~. malayi and~. pahangi has 
been shown to be successful in cats, dogs, and monkeys (Edeson and 
Wharton, 1958; Schacher, 1962; Edeson, 1960; and Nelson, 1959). 
The use of cats, dogs, or monkeys as laboratory hosts has severe limi-
tations due to size, handling problems, and expense. Attempts to 
introduce Brugia .§.QR• into commonly available laboratory rodents has 
met with varying degrees of success. 
Brugia ..§.P.P• infections in the multimammate rat (Praomys natalensis) 
have been shown to be successful. Petranyi and Mieth (1974) found 
that 76% of 92 males became patent after innoculation with 100 infec-
tive B. malayi larvae. Ahmed (1966) successfully infected 6 animals 
with B. pahangi with Benjamin and Soulsby (1974) employing this system 
in immunologic studies. 
The golden hamster, Mesocritcetus auratus, has also been success-
fully infected with Brugia ~., 35% will develop patent infections 
with~. pahangi and 20% with~. malayi (Ash and Riley, 1970; Harbut, 
1973; and Malone et. al., 1974). Adults worms have been recovered 
from the heart, pulmonary vessels, lymphatics, and testes. Infections 
in this system have been shown to be less desirable in comparison with 
other systems (as opposed to a jird system), due to its rather weak 
susceptability to infection. Recently, Malone et. al. (1979) indica-
ted that the inbred Syrian hamster(~. auratus), showed increased sus-
ceptability to infection with B. pahangi such that it could constitute 
(11) 
a suitable alternative to the jird. Attempts to infect the white rat 
with Brugia ~· have met with little success. Experimental trans-
mission of B. malayi in rats by Laing et. al. (1961) and Cheong et. 
al. (1967) found only 19% of 26 animals infected developed patent 
infections. In other studies by Ash and Riley (1970); Sucharit and 
MacDonald (197J); and Harbut (1973) rats were innoculated with in-
fective~. pahangi with only 15% showing patent infections. 
Experimental infection~ using Brugia ~· in mice has shown 
little encouragement. Laing et. al. (1961) and Ahmed (1967) could 
not demonstrate any signs of infection in mice innoculated with B. 
pahangi. Cheong and Wong (1967) innoculated J strains of mice with 
~. pahangi and were able to develop patent infections, with the re-
covery of adult worms from 2 individuals. However, Vincent et. al. 
(1980) demonstrated that all of 16 nude mice infected with 100 1 3 
~. pahangi would develop patent infections with worm recoveries in 
all animals at necropsy. Among 14 normal mice given 100 infective 
~. pahangi larvae, lJ worms were seen in short term infections (8 
days), but nine recovered from mice necropsied after 50 days. 
The most successful attempts to infect small rodents with Brugia 
~· have been demonstrated with the black clawed mongolian jird, 
M. unguiculatus. The jird has shown to be a susceptable host for 
B. malayi, ~. pahangi, and~. patei (Ash and Riley, 1970 and Ash, 
1971, 197J). Infections were established by subcutanious innocul-
ations with varying numbers of infective Brugia §J2£• larvae. Animals 
infected subcutaneously were shown to have adult worms establishing 
in the heart, lungs, pulmonary arteries, viscera, subcutaneous es-
(12) 
tablishment in the pelt and muscle tissue, in the lymphatics asso-
ciated with the testes, and in the seminiferous tubules (Ash and 
Riley 1970; Ash, 1971, 1973; Ab and Thompson, 1973; El Bihari and 
Ewert, 1971). Infective larvae innoculated intraperitoneally were 
found to develop freely to adults in the peritoneal cavity with 
little or no migation to the lymphatics and other organs (Ah and 
Thompson, 1973; MaCall et. al., 1973). Ash (1971) reported a mean 
prepatent period of 72 days for male jirds and 80 days for females 
infected with B. pahangi. El Bihari and Ewert (1973), found the 
mean prepatent period in jirds infected with B. malayi to be 129 
days in males and 117 days in females. 
Ash (1971) found preferential susceptibility to infection among 
male jirds over female jirds to~. pahangi; 82% of 17 males and 24% 
of 17 females became patent after subcutaneous innoculations of 25 
to 75 infective larvae. El Bihari and Ewert (1973) made similar 
observations between the 2 sexes when they were infected with B. 
malayi; 92% of 26 male and 43% of 21 female jirds became patent af-
ter subcutaneous innoculations with 20 to 105 inf'ective larvae. 
Westley (1973) through endocrine manipulation of both male and fe-
male jirds infected with~. pahangi, was able to show that resistance 
was androgen dependent. Resistance in female jirds was apparently 
due to estrogen. Devereux and Ash (1978) showed increased sus-
ceptability of female jirds with age. 
(13) 
Pathology in M. Unguiculatus due to Brugia §..12.I?.• 
Pathology due to lymphatic-dwelling Brugia §..12.I?.• has been demon-
strated in a variety of different anatomical locations. Ah and 
Thompson (1973) reported migration of infective larvae of~. pah-
angi to the regional lymphatics of M. unguiculatus. After being 
innor.ulated subcutaneously, infective larvae would migrate as early 
as 1 to 4 days post infection. Some injected larvae remained in 
the skin for as long as 30 days. Localization occured in the heart, 
lungs, pulmonary arteries, pleural cavity, with three-fourths re-
covered filaria found in the regional lymphatics. Major patholo-
gical changes were noted in involved regions. Severe inflammation 
appeared throughout the migratory pathways and infected tissues. 
Granuloma formation appeared around dead and developing larvae cre-
ating lymphatic and pulmonary obstructions. Lesions were noted in 
infected organ and tissue systems, both as a result of damage incur-
red by larval migration, as well as hyperimmune responses to inNad-
ing larvae. 
Vincent et. al. (1976) described the pulmonary pathology in M. 
unguiculatus due to Brugia §..12.I?.• infections. The major pathological 
changes include: (1) granulomas induced by larvae and adults; (2) 
obstructive endarteritis and; (3) chronic interstitial inflammation 
with degrading microfilaria. The majority of pulmonary granuloma 
formation occurred near the time of the final molt at 30 days post 
infection followed by involution and formation of residual vascular 
lesions over the next several months. A minority of granulomas a-
(14) 
rose about sexually mature adult worms and showed a characteristic 
sequence of development along the length of the worms. Obstructive 
endarteritis appeared to peak at about the same time as the final 
molt and became largely fibrotic by 125 days post infection. 
Vincent and Ash (1978) investigated splenic indices and hist-
ological changes in jirds infected with~. pahangi and B. malayi. 
Low Rplenic inniceR and a lack of histologic changes were observed 
for the first 2 months post innoculation. At the end of the prepa-
tent period, spleen weights were shown to be increasing with full 
mean value attained by the fourth month (post innoculation). 
Spleens from animals infected with~. malayi were roughly double the 
normal splenic index while in B. pahangi infections, indices were 
larger. 
"Histologic sections showed expansion of both red and white pulp; 
maximum follicular activity was observed in the third and fourth 
months post-innoculation and gradually waned in long term infections." 
Granulomas associated with microfilaria in tissue was a conspicuous 
feature with B. pahangi. Although no consistant relationship has 
been established between splenic reactions and microfilaria, Vincent 
and Ash feel that the increased splenic indices are due to increasing 
levels of microfilaria as well as excretory, secretory, products re-
leased by the adult worms. 
Immunology 
W. bancrofti 
(15) 
Our present knowledge of the immune response to lymphatic-dwelling 
filarial species is limited. Immunological studies with~. bancrofti 
are severely limited due to the lack of a suitable laboratory host, 
and the scarcity of homologous antigen. In the past, immunological 
studies involving Wuchereria §12J2• have involved cross-reaction tests 
with heterologous antigen in immunodiagnostics (Sasa, 1976). 
Natural and Acquired Resistance 
Brugia fl.IP• 
The susceptability of vertebrates to infection with Brugia ~· 
varies between and within species. Studies on domestic cats have 
shown Malayan cats to have a higher rate of patency than do English 
cats. Ash (1971) demonstrated preferential susceptability of male 
jirds to infection with Brugia §12J2• as opposed to female jirds. 
Wesley (1973) showed that this resistance was androgen dependent, 
not due to the presence of estrogen, Wesley and Ash (1972) showed 
gonadectomy and injections of testosterone considerably altered pat-
ency rates in jirds but do not vary according tn,sex. 
Denham eto al. (1972) repeatedly infected cats every 10 days by 
injecting 50 infective~. pahangi larvae into their left hind foot 
pads and found of the animals had suddenly lost their circulating 
microfilaria. These studies were extended to include the specific 
(16) 
response of repeatedly infected cats. Denham found that after re-
peated infections, the cats became resistant to new challenges by in-
fective larvae. At necropsy, live adult worms were found in the 
lymphatics and microfilaria in the popliteal nodes. Resistance 
was theorized as probably the result of acquired immunity and of 
pathological changes in the lymphatics. The degree of resistance 
was found to be directly proportional to the degree of lymphatic 
damage. 
Kowalski and Ash (1975) studied repeated infection with~. pah-
angi in M• unguiculatus. After repeated subcutaneous infections 
(innoculations), a moderate degree of resistance was seen. Adult 
worm recoveries from singly infected animals was 15% to 16% as op-
posed to repeatedly infected animals at 8% to 10%. 
Attempts at vaccinations against filarial infections using gamma-
irradiated larvae of Brugia ~· has met with varied success. 
Wong et. al. (1969) conducted the first filarial vaccination exper-
iments using subperiodic ~. malayi in Macaca mulatta. Two innocula-
tions were able to stimulate protective immunity which lasted 10 to 
12 months. The vaccinated animals never became patent, however, de-
veloped cryptic infections. 
The induction of immunity against developing larvae and adults 
was demonstrated by Ah eto al. (1974) using~. pahangi in dogs. 
Six dogs were vaccinated subcutaneously with 500 infective larvae 
attenuated with 22.5 krad of gamma radiation. All 6 dogs became 
patent, however, 4 of the dogs showed suppression of microfilaria. 
In addition, the recovery of adult worms was reduced by 57%, with 
( 17) 
2 dogs showing no adult worms at :necropsy. Ramachandran (1970) in 
an attempt to immunize cats against ~o malayi was unable to induce 
immunityo The failure to induce protection with Brugia §12£• in 
cats appears to be dose related; a large stimulus is needed to 
invoke protective immunity. 
Schistosoma mansoni has been shown to evade the hosts immune res-
ponse by the acquiring of host, or host-like antigens on their sur-
faces (Smithers et. al., 1969; McLaren et. al., 1975). Mcgreeve 
et. al. (1975) attempted to show that B. pahangi protects itself 
in a similar fashion. The first attempt was to demonstrate the in-
corporation of mosquito antigen on third stage larval cutica. Cats 
immunized with thoracic flight muscles of Aedes aegypti followed by 
immunization with third stage larvae from this vector showed no 
differences in infectivity and subsequent worm recoveries. A second 
approach of immunizing jirds with cat antigens then transfering a-
dult worms and microfilaria from the cats to the immunized hosts, 
also met with failure, showing that~. pahangi does not evade the 
immune response as do schistosomes (Denham and McGreevy, 1977). 
Basic Studies 
Weller (1978) studied cell mediated immunity during chronic in-
fections with Bo pahangi in inbred Lewis rats. Microfilaria were 
demonstrated in over 90% of the rats by 16 weeks. Using in vitro 
lymphocyte blastogenesis, cell mediated immune responses of blood, 
splenic, and mesenteric node lymphocytes were followed during a year 
(18) 
and 6 months of infection. Lymphocyte responses to infective stage 
larvae were shown demonstratable in the first weeks of infection, 
whereas responses to microfilarial antigen only developed later 
on in the course of infection as microfilaremias waned. Lymphocyte 
responses to the adult filaria vacillated during the infection. 
Portaro et. al. (1977) employed lymphocyte transformation techni-
ques for the detection of~- pahangi antigens in infected jirds. 
Portaro demonstrated that. lymphocyte populations could determine 
and discriminate different types of filarial antigens. 
Vincent et. al. (1980) infected normal and nude mice with 100 
infective larvae of~. pahangi subcutaneously. Normal mice showed 
only short term infections (8 days) with no adult worms recovered 
after 50 days. In contrast, all nude mice developed patent infec-
tions persisting as long as 240 days post innoculation, with micro-
filaremias ranging from 2 to 600 per 20 mmJ of peripheral blood. 
In the absence of a functional thymus, the nude mouse is severely 
deficient in its ability to generate cytotoxic effector cells to 
respond to T-dependent antigens. The results suggested that resis-
tance to Bo pahangi infections is directed against immature stages 
and depends upon the presence of T-lymphocytes. 
Piessens et. al. (1980) investigated the mechanisms of specific 
immune unresponsiveness to microfilarial antigens in the blood of 
(human) patients infected with~. malayi. Blood from these indi-
viduals was shown to contain an adherent cell type that specifically 
suppresses reactions to microfilarial antigens, but not other anti-
gens. In the absence of continued stimulation by parasite antigens, 
(19) 
this suppressor cell looses its functional activity after overnight 
culture in vitroo These suppressive reactions were also found in 
serums from patients without microfilaremias, suggesting that im-
mune unresponsiveness in humans with patent infections is due to 
active suppression of immune responses directed against the parasite 
by the patients own immune system, but not an intrinsic inability of 
infected patients to react to parasite antigens. 
Immunodiagnostics 
Lymphocyte Transformation: 
The use of lymphocyte transformation for the detection of filarial 
infections was employed by Portaro et. al. (1977). Using B. pahangi 
infected jirds, Portaro was able to demonstrate that lymphocyte pop-
ulations could discriminate between 2 types of filarial antigens. 
This technique was also shown to be capable of distinguishing fil-
arial antigens from those of Trichinella, suggesting its usefulness 
in the specific detection of filarial infections for clinical and 
epidemiological work. 
Immunofluorescent Antibody Test 
The application of the indirect fluorescent antibody test for 
the diagnosis of filarial infections has been widely employed (Rid-
ley and Hedge, 1977; Sasa, 1976; Barbosa et. al., 1972; Grove and 
Davis, 1978)0 
Barbosa eto al. (1972) used heterologous antigen fragments of 
(20) 
O. volvulus in the detection of 1• loa and~. bancrofti infections 
in human subjects. Successful cross reactivity was demonstrated; 
reactions in which antibody titers were shown to be 1:40 or higher 
were considered positive. Nineteen out of 20 patients infected with 
either 1• loa or~. bancrofti, or both, were shown to be positive. 
To further demonstrate the sensitivity and specificity of the test, 
filarial antigens were used in sera from 50 ancylostimiasis or st-
rongyloidiasis cases, and 50 control seras, in all cases, the tests 
were negative. Grove and Davis (1978) employed indirect immuno-
fluorescence to measure antibody titers to~. malayi and W. bancrofti 
in human subjects living in endemic regions. ~. malayi was used as 
the source of antigen with a positive reaction demonstrable at 1:8 
or higher. All the subjects tested showed positive titers ranging 
from 1:8 to 1:1,024 with control subjects negative. 
Indirect Hemagglutination 
Work done by Benjamin and Soulsby (1976) on the homocryptic 
and hemagglutinating antibody responses to B. pahangi infections 
in Mastomys natalensis indicates the level of free antibody in the 
sera remains relatively low (peak titer; 1:512) and does not in-
crease 60 days post infection (in patent infections). Kowalski (un-
published, work in progress) indicates that hemagglutinating antibody 
levels in jirds infected with B. pahangi appear about J to 4 weeks 
post infection. 
In other work done with Lo Carinii in hemagglutination studies, 
Tanaka et. al. (1969) and Sasa (1976) show titers as high as 1:16,384, 
(21) 
demonstrating a high degree of sensitivity and specificity with this 
test. 
The Complement Fixation System 
Complement is a thermolabile complex of 11 serum proteins present 
in most vertebrates. The concentration of complement appears to 
be stable except in times of 8n~igP.nic ch8llP.ngP.. In conjunction 
with specific antibody, this series of proteins becomes activated and 
will combine with an antigen-antipody complex. Following fixation, 
complement will proceed in an orderly and sequential fashion referred 
to as the complement cascade. The end result being (potentially) 
the elimination of the antigen. Since the fixation of complement pro-
ceeds without visible changes in vitro, a hemolytic system consis-
ting of sheep erythrocytes sensitized to a rabbit anti-sheep eryth-
rocyte antibody (hemolysin) must be used to indicate complement 
activity. 
In the complement fixation test (Figure 1), known quantities of 
antigen are added to serially diluted quantities of antisera. Anti-
gen-antibody complexes are allowed to form, followed by the addition 
of complement. Complement is next allowed to fix with the antigen-
antibody complexes overnight before the addition of sensitized sheep 
erythrocytes. After these sensitized cells are added, unbound com-
plement will combine with the erythrocyte-hemolysin complex, causing 
the erythrocytes to lyse. If the sensitized cells have not lysed, 
all the available complement was bound by the antigen and test serum 
complex. The degree or level of antibody in the test sera to the 
(22) 
specific antigen is measured by the percentage of lysis seen in the 
- -
hemolytic system. 
The preparation for the complement fixation test employs several 
biological reactions requiring careful standardization. The speci-
fic titration of hemolysin, complement, and test antigen are necess-
ary to quantitate optimal amounts before the test can be used. 
Complement fixation tests have been widely employed in both nema-
tode infections and viral infections. Tanaka et. al. (1969) employed 
the complement fixation test with adult L. carinii antigen and sera 
from cotton rats infected with L. carinii. Antigen titers from in-
fected serum tested showed positive titers ranging from 1:16 to 1:1024. 
In a related study, Tanaka et. al. (1970) demonstrated cross-reactiv-
ity in complement fixation testing among filarial species. Antigens 
derived from Dirofilaria immitis, 1• carinii, and Setaria cervi were 
found to cross-react to serum from subjects infected with~. malayi, 
W. bancrofti, Apodems specious, Q. witei, and each other, showing a 
small degree of species specificity. 
Thesis 
As has been previously described (Ash and Riley, 1970; Ash, 1971; 
Denham and McGreevy, 1977; Porataro et. al., 1977; Kowalski and Ash, 
1975) the male jird, Mo unguiculatus is an effective laboratory model 
for study with lymphatic-dwelling Brugia ~· The jirds size, ease of 
handling, cost, and relatively short lifespan (2 years or more), make 
it a preferred system over the normal cat host. The selection of B. 
pahangi over that of~. malayi is due to the latter's high infectivity 
(2J) 
towards the human host as opposed to that of B. pahangi. Although£• 
pahangi has been demonstrated infective in man (Buckley, 1958) risk 
of infection is generally poor and less likely than to that of B. 
malayi. 
Little or no work using homologous antigen has been done in comple-
ment fixation testing with either W. bancrofti or Brugia ~·· To 
date, no work has been performed to characterize antibody levels in 
jirds infected with B. pahangi over an extended period of time using 
the complement fixation system. Studies performed by Kowalski and 
others using indirect hemagglutination have demonstrated titers as 
high as 1:512 in jirds infected with£• pahangi. Further studies by 
Kowalski (unpublished) show antibody appearing in the sera as soon 
as J to 4 weeks post-innoculation, with titers leveling off after J 
to 6 months. Jird serum samples were collected prior to infection, 
with£• pahangi and post infection, varying up to 20 months. The 
application of these serum samples using homologous antigen in the 
complement fixation assay is hoped to further characterize antibody 
titers during infections with lymphatic-dwelling filaria. Using 
this system, further insight will be gained to the host-parasite 
relationship and the immunological response during that time. 
(24) 
Materials and Methods 
Experimental Animals: 
The black clawed mongolian jird, Mo unguiculatus served as the 
definitive host for~. pahangio The animals were obtained from Tum-
blebrooke Farms, Westgate, Massachusetts. Seven to 16 week old male 
jirds were infected with either 100 or 200 infective stage larvae 
(13 ), of B. pahangi. 
Intermediate Mosquito Host: 
The intermediate mosquito vector, A. aegypti (selected Liverpool 
strain), were cultured using standard methods adapted from Barr 
(1964) and McDonald (1962). Mosquitoes were allowed to feed on 
anaesthetized jirds. (10% Na Nembutal solution in sterile water: in-
jected intraperitoneally in accordance with body weight: O.Olml/gr. 
wt.) which had microfilarial densities between 75 and 100 microfil-
aria per 20 mmJ of peripheral blood at the time of infection. In-
fected mosquitoes were maintained at a temperature of 80°F. to 
8J°F. with a relative humidity of 80% for 12 to 14 days, after which 
time, the mosquitoes were killed and the mature larvae were isolated. 
Infection Technique: 
Infected mosquitoes were vacuumed out of their cages and trans-
fered to large test tubes immersed in ice. After cold stunning, 
the mosquitoes were placed on large size petri dishes, crushed and 
then transferred to Baerman funnels containing Hanks Balanced Saline 
(25) 
with 4 layers of gauze at the topo The funnels containing the crushed 
mosquitoes were left standing at room temperature for 1 hour to allow 
the larvae to migrate to the bottom of the funnels. Larvae were 
collected in a watch glass. Doses of 100 or 200 infective larvae 
were separated under a dissecting microscope using silicone treated 
Pasteur pipettes. Doses of infective larvae were pipetted and/or 
injected with tuberculin syringes. - I • • . • -, The left ana;or right groins ot 
the experimental animals were shaved and a needle inserted to make an 
artificial subcutaneous pocket. The larvae were injected or pipetted 
into these pockets with no more than 0.2 ml. of fluid. 
Collection of Serum 
Animals were bled via the orbital sinus using sterile 5 J/4" Pas-
teur pipettes. 0 One ml. of serum at each bleeding was stored at -70 C. 
until usedo Serum samples were taken the day of innoculation and 
weekly for 4 weeks, thereafter at monthly intervals. Samples were 
collected over a 12 month period, with a final sample being taken at 
necropsy. Microfilaria densities were monitored bi-weekly for up to 
1 year 9 thereafter at monthly intervals. 
Determination of Microfilaria: 
Samples (20 mm3) of peripheral blood (collected via the orbital 
sinus) were placed in tubes containing 0.2 ml. formalin. Microfil-
aria were counted under a light microscope. 
(26) 
Preparation of Homologous Antigen: 
~o pahang~ adults from jirds, previously innoculated with 400 13 
larvae, (from Dro John McCall, University of Georgia), served as homo-
logous antigen. Adult male and female worms (isolated from the jird 
hosts), were placed in a Pyrex tissue grinder and homogenized in 
phosphate buffered saline (PBS), pH 7.2. The homogenate was soni-
cated, and ultracentrafuged at 50,000xg for 1 hour. The soluble por-
tion served as the homologous antigen (extracted whole adult male and 
female B. pahangi worms). 
The Complement Fixation System: 
The complement fixation assay used was adapted from: Standard-
ized Diagnostic Complement Fixation Method and Adaption to Micro-
Test (HEW Report, 1965). 
Preparation of Sheep Red Blood Cells (SRBC's) 
SRBC's in Alserver 0 s solution were washed J times in veronal buf-
fered diluent (VBD). After the third washing, 1 ml. of packed cells 
was added to 34.7 ml. of VBD, effected a 2.8% suspension. 
Preparation of Color Standards: 
Eleven serological tubes were labeled 0% through 100% with each 
designate corresponding to the percentage of hemolysis as would be 
observed using the 2.8% suspension in the test system. A 0.28% hemo-
globin solution was prepared by adding 1.0 ml. of the 2.8% suspension 
to 7o0 ml. of water (effecting total lysis) then adding 2.0 ml. of 
concentrated VBD to the solution" A 0.28% SRBC suspension with 
(27) 
9.0 ml. of VBD buffer. One ml. of the 0.28% suspension was placed 
in the 0% tube, with the 10% tube receiving 0.9 ml. of the 0.28% 
SRBC suspension and 0.1 ml. of the hemoglobin solution, so on in this 
fashion. The tubes were centrifuged and the resultant coloration of 
the increasing hemoglobin solutions through the tubes corresponded 
to the percent lysis that would be observed through the tests. 
(28) 
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Figure 1; Diagrammatic representation of positive and nega-tive complement fixation tests (Adapted and taken from: Methods in Immunology; fhird Edition, Pg. 402; Garvey, Cremer & Sussdorf; 1977; W.A. Benjamin, Inc.) 
(29) 
Hemolysin Titration: 
The hemolysin titration proceedure was used to determine the optimal 
amount of hemolysin required for adequate sensitization of the SRBC's 
(to effect a 50% end point). 
One ml. of the 2.8% SRBC suspension was placed in tubes with 1.0 
ml. of varying dilutions of hemolysin in VBD buffer (1:100 through 
1:8000). The tubes were then incubated for.JO minutes in a 37°c. 
waterbath. The dilutions _of sensitized cells (0.2 mls. of each dilu-
tion), were added to fixed amounts of VBD buffer (0.4 ml.) and Guinea 
Pig complement (0.4 mls. of a 1:400 dilution in VBD buffer). The 
suspensions were incubated for 1 hour in a 37°c. water bath, centra-
fuged and the percentage of hemolysis read against the color standards. 
Complement Titration: 
The titration of complement follows in much the same fashion as the 
hemolysin titration. Varying dilutions of Guinea Pig complement (C') 
were added to a fixed amount of optimally sensitized SRBC's and incu-
bated for 1 hour, in a 37°c. water bath, centrifuged, and read against 
the color standards. The procedure for the C' titration is listed in 
Table 1. 
Table 1. 
_A_d_de_d_i_n_O_r_d_e_r_: _____ T_u_be_N_o:.,_._: _ ___:_( .:::..1..!--) ___ ('-2-=-) ___ _,('"""3'-""-) ___ -.l,(.,,;.4..,t....) __ 
(1) VBD buffer: o.8 ml. o.6 ml. 0.55 ml. o.4 ml. 
(2) 1:400 C': 0.0 ml. 0.2 ml. 0.25 ml. 0.4 ml. 
(J) Optimally Sensitized SRBC's: 0.2 ml. 0.2 ml. 0.2 ml. 0.2 ml. 
(JO) 
The percentage of lysis (Y) was determined in each assay tube by 
direct comparison with the color standards. The (Y) value was used 
to determine the quantity of diluted complement (Y/1-Y), and plotted 
on log-log paper, (Fig. 2). Straight lines were drawn through the 
plotted points on both sides of the vertical "1" line. The midpoint 
of each straight line was then determined, followed by a line drawn 
connecting the 2 midpoints. The quantity of diluted complement pro-
ducing 50% lysis was found from the intercept of the plotted line 
and the vertical "1" line. The intercept on the vertical axis was 
determined to be 0.26, therefore 0.26 ml. of diluted complement 
(1:267) equalled lC 1 H50 unit. The complement fixation master test 
employs 5C'H50 units; therefore; 1.J mls. of a 1:267 dilution 
equalled the 5C'H50 units. Due to the scarcity of homologous antigen, 
further titrations and the complement was adapted to a microplate 
system in "C" plates. In the microtest, 0.5 ml. of diluted comple-
ment containing 5c 0 H50 units were needed. The subsequent complement 
dilution was scaled down to accomplish this with a 1:10 dilution of 
complement in VBD buffer. 
Antigen Titration: 
The optimal dilution of antigen is defined as that dilution which 
gives the highest complement fixing antibody titer with a specific 
standard antisera. The optimal dilution is determined using a JO% 
lysis end point. 
Due to the scarcity of~. pahangi antigen, the rest of the assay 
was adapted to a microtiter system. The microtiter system simply re-
(31) 
duces the amounts of materials used by a factor of 10. The assay was 
performed in "U" shaped microplates. 
The antigen titration was performed by adding varying antigen di-
lutions (in VBD buffer; with dilutions of 1:25 through 1:256,000) to 
varying antisera dilutions (in VBD buffer; with dilutions 1:4 through 
1:256) with a constant amount of complement were allowed to react over-
night before adding the optimally sensitized SRBC's. After the addition 
of the sensitized cells, the plates were incubated at 37°c. for 30 
minutes, allowed to settle, and the percent hemolysis read against 
the color standards. 
The Complement Fixation Test: 
After successful completion of the preliminary titrations, the com-
plement fixation assay was performed using the optimal dilutions of 
the titrated materials against the test seras. 
The jird test sera was diluted in VBD buffer with the range of 
dilution being 1:4 through 1:512. After the dilutions of the test 
sera was made, the optimally diluted~. pahangi antigen was added 
and allowed to react for 15 minutes at room temperature before add-
ing complement. After the addition of complement, the plates were 
allowed to react overnight before the addition of the sensitized 
SRBC 0 s. Upon the addition of the SRBC's, the plates were sealed 
and incubated for 30 minutes at 37°c. and then allowed to settle 
overnight. The amount of hemolysis was read against the color stan-
dards. The last well showing 30% lysis was regarded as the highest 
antibody titer. 
(32) 
Results: 
Infection with~. pahangi in M• unguiculatus: 
Male outbred jirds (M. unguiculatus), were innoculated with doses 
of 100 or 200 infective~. pahangi larvae (13
1 s). Animals were di-
vided into 2 groups by 1 3 dosage levels, 100* or 200**· Following 
innoculation, all test animals became positive for microfilaria 
in the peripheral blood. 'Seventeen of 20 test animals developed in-
fections within or shortly after 60 days, with the longest prepatent 
period being 118 days. Readings of microfilarial densities were 
taken after the first month, through 12 months, with the final micro-
filaria reading between 12 and 21 months. Microfilarial densities 
vacillated through the course of infection (Table 2). 
At the time of necropsy, adult worms were recovered from the testes, 
heart and pulmonary regions, pelt and carcus, and viscera. The adults 
recovered were first divided by sex, then counted for the particular 
area. The majority of the recovered adults were found in either the 
testicular region or the pulmonary region. The percentage of males 
to females vacillated between necropsied regions and from animal to 
animal (Table J). These results do not show definative ratios between 
males and females recovered, either from the individual area or total 
animal. In most cases, animals which received 200 1 3 dosages as 
opposed to those which received 100 1 3 dosages, show a higher total 
worm recoveryo 
In both sets of data (Tables 2 and J), control subjects were shown 
to be negative for microfilaria and adult male and female worms. 
(33) 
Hemolysin Titration: 
Varying amounts of rabbit anti-sheep red blood cell antibody (hemo-
lysin) were titrated against constant amounts of complement and SRBC's. 
The optimal amount of hemolysin required for the adequate sensitiza-
tion of the SRBC's was determined (Figure 2). Several hemolysin 
titrations were performed to determine consistency in testing and 
results. Reading from left to right in Figure 2, the greatest percen-
tage of SRBC hemolysis (85%), was observed with the 1:1000 dilution 
followed by consistent 70% hemolysis for dilutions 1:1500; 1:2000; 
and 1:2500. After 1:2500, resulting hemolysis percentages for 
1:3000; 1:4000; and 1:8000 dropped sharply to as low as 35% hemolysis. 
The optimal dilution as determined in Figure 2, was taken as the sec-
ond point on the plateau (graphically) where varying hemolysin dilu-
tions showed a consistent percentage of hemolysis of SRBC's. The 
1:2000 dilutions were found to be the optimal amount of hemolysin 
needed for adequate sensitization of the SRBC's. 
Complement Titration: 
In complement titration a 50% hemolytic endpoint was used to de-
termine the potency of the complement. The protocol for complement 
titration has previously been described (Table 1), and performed in 
triplicateo Varying volumes of a constant dilution of complement 
plotted against increasing hemolytic endpoints (Y/1-Y) show that the 
midpoint of the intercept line coincides with a .26 ml. volume of 
complement on the vertical axis. As previously described (Materials 
and Methods: Complement Titration), the complement master test em-
(34) 
ploys 5C'H50 units. Therefore, 1.J mls. of the 1:267 dilution of 
stock complement was 5 times the amount needed to lyse 50% of the 
sensitized SRBC's in a 2.8% suspension with VBD buffer. 
Antigen Titration: 
Varying antigen dilutions were compared with varying standard 
antisera dilutions (Table 4). A curve drawn around the 1:25 and 
1:50 dilutions is shown, without being anti-complementary. The di-
lution of 1:50 was chosen over that of 1:25 due to the scarcity of 
homologous antigen. The complement-antigen controls show adequate 
hemolysis corresponding directly with the amount of C1 H50 units 
used with any sign of anticomplementary activity. 
Complement Fixation Testing: 
Test animals were divided into 2 groups: those with consist-
antly low microfilaremias throughout the course of infection 
(Group A); and those with consistantly high microfilaremias through-
out the course of infection (Group B) (Table 5). The dividing point 
for each group was made in correspondence with term microfilarial 
densities (Table 2), and a microfilarial count taken at the time of 
necropsy. Animals with densities below 500 microfilarie per 20 mmJ 
of peripheral blood were considered low (Group A), and those greater 
than 500 were considered high (Group B). 
Reciprocal antibody titers for complement fixation testing are 
shown for samples taken the day before infection, at 1.5 months, to 
J month intervals with post 12 month samples ranging from 12 to 21 
(35) 
months. Complement fixation testing between groups A and B for each 
sample and month were performed on the same day to establish consis-
tency in testingo Both groups, A and B, showed patterns of consistent 
increases in complement fixing circulating antibody to the homologous 
~. pahangi antigen. Eighty percent of the animals in group A showed 
positive antibody titers at 6 weeks post-innoculation with 100% of the 
animals in group B positive during the same period. Antibody titers, 
after 6 weeks, in both gr~ups, were shown to be positive 90% to 100% 
throughout the course of infection, with increasing means with time 
(Table 5). The mean and standard error are shown for each group (Table 
5). The Mann-Whitney Q test for non-parametric statistical analysis 
between means was employed (Sokal and Rohlf, 1969). Significant 
differences between means were demonstrated at 3, 6, and post 12 month 
periods. The P values for months, 3 and 6 were shown to be less than 
0.05 (P~ .05) with the post 12 month P value being less than 0.01 
(P= .01). Antibody titer means for group A and Bare depicted graph-
ically in Figures 3 and 4, respectively, with the differences between 
means demonstrated in Figure 5. The reciprocal antibody trends for 
both groups combined with complement fixing circulating antibody 
titers ranging from 1:4 to 1:256 were obtained (Figure 6). 
All control animals tested negative for antibody to B. pahangi 
antigen in complement fixation testing. 
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als 
a
re
 divided into 3 groups by 
the n
u
m
ber 
of infected larvae 
e
a
ch 
re
cieved (100*, 
200**, 
o
r n
o
n
e*
*
*) 
A
dult 
w
orm
s 
re
c
o
v
e
red 
a
t 
n
e
c
ropsy a
re
 
also dem
onstrated. 
Table 2 
B. 
pahangi M
icrofilarfal D
ensities per M
onth Post-Innoculation 
a
nim
al 
D
ate 
A
dult 
w
orm
s 
M
onths Post Innoculation/M
icrofilariae per 20 
m
m 3 
of Blood 
Num
ber 
Infected 
R
ecovered 
1 
2 
3
-
4 
5 
-6 
7 
8 
-
9
-
-1
 o
-
_
_
 
1_1_ 
12 
Final M
f. 
-
-
-
-
-
288* 
11-11-78 
17 
0 
2 
36 
16 
3 
39 
12 
34 
38 
44 
62 
47 
47 
289* 
11-11-78 
37 
0 
2 
5 
']60 
131 
123 
194 
210 
333 
593 
284 
499 
401 
290* 
11-11-78 
34 
0 
1 
11 
15 
7 
54 
31 
86 
212 
166 
200 
168 
297 
291* 
11-11-78 
34 
0 
1 
41 
298 
146 
113 
17 
16 
18 
83 
75 
12 
12 
293* 
11-11-78 
18 
0 
0 
27 
'189 
311 
487 
434 
525 
675 
469 
802 
+500 
+500 
333* 
3-2-79 
29 
0 
19 
24 
17 
18 
42 
25 
58 
44 
1 
23 
9 
0 
334* 
3-2-79 
39 
0 
0 
0 
0 
15 
4 
2 
1 
0 
0 
3 
6 
1 
335* 
3-2-79 
30 
0 
37 
36 
0 
0 
0 
0 
0 
0 
0 
1 
0 
1 
336* 
3-2-79 
32 
0 
27 
'136 
234 
280 
509 
309 
232 
104 
191 
571 
493 
+500 
338* 
3-2-79 
29 
0 
34 
149 
178 
289 
429 
484 
801 
807 
626 
+1000 
+2000 
+500 
339* 
3--2-79 
32 
a
 
5 
14 
1 
11 
0 
0 
0 
0 
296** 
11--15-78 
34 
0 
13 
313 
466 
992 
709 
523 
301 
438 
639 
1076 
438 
+500 
297** 
11--15-78 
41 
0 
1 
40 
91 
247 
410 
377 
275 
225 
394 
248 
235 
+500 
301** 
11--15-78 
59 
0 
2 
99 
136 
394 
515 
473 
932 
338 
435 
679 
617 
+500 
302** 
11--15-78 
38 
0 
6 
22 
0 
35 
16 
49 
37 
52 
40 
63 
61 
61 
345** 
3--28-79 
30 
0 
0 
30 
60 
77 
26 
117 
20 
253 
222 
7500 
406 
+500 
349** 
4--22-79 
21 
0 
1 
23 
6 
46 
16 
4 
0 
12 
21 
3 
173 
2 
350** 
4--22-79 
58 
0 
12 
67 
214 
472 
569 
211 
260 
494 
352 
+500 
+1000 
+500 
351** 
4--22-79 
22 
0 
5 .. 
62 
128 
80 
113 
176 
46 
380 
227 
457 
+800 
+500 
C
ontrols 
340*** 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
341*** 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
353*** 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
*
 Infected 
w
ith 100 13 
.1?_. pahangi 
*
*
 Infectec 
w
ith 200 13 
.1?_. 
pahangi 
*
*
*
 NO 1 
's
 
3 
-
-
Dead 
+
 G
reater than 
"""" 
('-
C""\ 
.
.
.
.
_
.
.
 
Table 3: 
A
dult~. pahangj: 
re
c
o
v
e
red 
at 
n
e
c
ropsy a
re
 
show
n. 
M
ales 
and fem
ales from
 4 a
n
atom
ical 
a
re
a
s 
of 
re
sidence is 
shoi.,m
, 
w
ith to
tals for 
m
ales 
and fem
ales, 
and 
to
tal 
w
orm
 burden 
re
c
o
v
e
ries 
Table 3 
A
nim
al 
Num
ber 
288 
289 
290 
291 
293 
311 
333 
334 
335 
336 
338 
339 
296 
297 
301 
302 
345 
349 
350 
351 
C
ontrols 
340 
341 
353 
B. 
pahangi 
I3 Num
ber 
100 
100 
100 
100 
100 
100 
100 
100 
100 
100 
100 
100 
200 
200 
20C 
200 
200 
200 
200 
200 0 0 0 
A
dult §_ •. 
pahangi R
ecovered 
at N
ecrops~ 
T
estes 
M
ales/Fem
ales 
6 8 7 8 5 
11 
11 
19 1 3 7 7 
11 5 
30 7 
18 2 
14 4 0 0 0 
7 8 
14 4 8 7 
13 
14 0 1 4 4 
17 
10 
20 
21 8 1 4 3 0 0 
0 
H
eart &
 Lungs 
M
ales/Fem
ales 
3 8 3 
16 1 7 1 4 8 
16 7 8 3 6 3 6 3 
10 
'16 6 0 0 0 
1 6 4 6 0 0 1 2 9 
12 5 8 5 9 6 4 1 8 
13 8 0 0 0 
P
elt &
 C
arcus 
M
ales/Fem
ales 
0 3 0 0 3 0 1 0 2 0 3 4 3 
0 0 0 0 0 0 0 0 0 0 
0 3 1 0 1 1 1 0 9 0 3 1 'I 
2 0 0 0 0 1 0 0 
0 0 
V
iscera 
M
ales/Fem
ales 
0 0 0 0 0 0 1 0 0 0 0 0 
0 1 0 0 0 0 0 0 
0 0 0 
0 0 0 0 0 0 0 0 1 0 0 0 
0 1 0 0 0 0 0 0 
0 0 0 
T
otal 
M
ales/Fem
ales 
9 
19 
10 
24 9 
18 
14 
23 
11 
19 
17 
19 
17 
12 
33 
13 
21 
12 
30 
10 0 0 0 
8 
17 
19 
10 9 8 
15 
16 
19 
13 
12 
13 
23 
21 
26 
25 9 9 
28 
12 0 0 0 
A
dult W
orms 
R
ecovered ( Tota: 
17 
37 
29 
34 
18 
26 
29 
39 
30 
32 
29 
32 
41 
34 
59 
38 
30 
21 
58 
22 0 0 0 
,..,.._
 
~ '-" 
Table 4 
B. 
pahangi A
ntigen T
itration (Block T
itration Table) 
A
ntigen 
A
ntisera D
ilutions in VBD B
uffer 
Com
plem
ent-A
ntigen C
ontrols 
D
ilution 
1: 2 
1: 4 
1 :8
--1
: 16 
-
-
1
:3
2
 
1 :64 
1:128 
5C'H
50 
2.5C
1H50 
1.25C
1H50 
-
-
-
-
-
-
-
-
-
-
-
1:12.5 
0 
0 
40 
60 
95 
100 
100 
100 
95 
70 
1: 25 
0 
20 
40 
60 
100 
100 
100 
100 
95 
70 
1: 50 
10 
20 
50 
60 
100 
100 
100 
100 
95 
70 
1:100 
10 
20 
50 
75 
100 
100 
100 
100 
95 
70 
1 :200 
10 
20 
50 
80 
100 
100 
100 
100 
95 
70 
: :400 
10 
20 
75 
90 
100 
100 
100 
100 
95 
70 
1 :800 
10 
20 
70 
90 
100 
100 
100 
100 
95 
70 
1: 1600 
10 
20 
70 
90 
100 
100 
100 
100 
95 
70 
1:3200 
10 
20 
70 
90 
100 
100 
100 
100 
95 
70 
1: 6400 
10 
20 
70 
90 
100 
100 
100 
100 
100 
70 
1: 12800 
10 
20 
70 
90 
100 
100 
100 
100 
95 
70 
Percentage 
of H
em
olysis 
of SRBC's 
Com
plem
ent-VBD B
uffer C
ontrols 
100 
100 
80 
T
able 4 
show
s 
the block titratio
n
 
o
f£
· pahangi 
against 
a 
standard jird 
a
n
tisera (anti-~. 
pahangi) 
~
-
pahangi 
a
n
tigen dilutions (vertical1, 
a
re
 titrated 
against jird 
a
n
ti-~. pahangi 
a
n
tisera (hori-
z
o
n
tal), 
in the presence 
of C' 
and 
s
e
n
sitized SRBC's. 
Percentage 
of hem
olysis 
of the 
s
e
n
sitized 
c
ells 
a
re
 
show
n. 
The 
optim
al dilution for testing is 
show
n in the 
c
u
rv
e
. 
-J
\ 
0
\ 
'
-
"
'
 
*
 No 
sam
ple 
+
 G
reater than 
-
Less than 
NS N
ot 
significant 
Table 5: 
R
eciprocal 
a
ntibody titers to
 B. 
pahangi 
se
e
n
 during 
co
m
plem
ent fixation testing 
of 
infected~
. 
u
nguiculatus 
s
e
ra
. 
T
est 
a
nim
als 
w
ere divided into 2 groups by 
m
icrofilarial densi-
ties. 
G
roup A
 being less than 500 
and group B
 being greater than 500. 
M
ean 
and 
standard 
e
rro
r 
is 
shown for; 
re
c
o
v
e
red 
adult B. 
pahangi 
a
t 
n
e
c
ropsy; 
and 
the 
re
ciprocal 
a
ntibody titers, for 
both groups 
and 
to
tal. 
The M
an~-W
hitney U
 te
st for 
n
o
n
-param
etric 
a
n
alysis betw
een 
m
eans is 
shoi,m
 
w
ith 
significant differences during-the third, 
sixth 
and post 12 
m
o
nth periods. 
Table 5 
M. 
u
nguiculatus R
eciprocal A
ntibody T
iters to
£
· pahangi 
A
nim
al 
A
dult W
orms 
M
icrofilariae 
M
onths Post-Innoculation/R
eciprocal A
ntibody T
iters 
Num
ber 
R
ecovered 
At N
ecropsy 
0 M
o. 
1. 5 M
o.· 
3 M
o. 
6 M
o. 
.2_ M
o. 
12 M
o. 
+12 Mo 
.
 
-
-
-
-
-
-
-
-
333 
29 
0 
0 
32 
32 
32 
32 
32 
64 
339 
32 
0 
0 
64 
32 
32 
32 
*
 
*
 
334 
39 
1 
0 
16 
32 
32 
64 
64 
*
 
335 
30 
1 
0 
64 
16 
64 
128 
128 
256 
349 
21 
2 
0 
8 
0 
8 
8 
16 
64 
<i:: 
291 
34 
12 
*
 
32 
64 
64 
64 
128 
128 
o
. 288 
17 
47 
*
 
0 
0 
0 
4 
4 
*
 
::l 
0 
302 
38 
61 
*
 
32 
16 
64 
64 
8 
128 
s:... 
34 
297 
*
 
8 
32 
32 
32 
128 
128 
CJ 
290 
289 
37 
401 
*
 
0 
16 
16 
16 
32 
64 
M
ean 
31 
.
 100 
82.200 
0.000 
25.600 
26.667 
34.400 
44.400 
60.000 
118.857 
Standard E
rror: 
0.000 
7.520 
5.963 
7,356 
11.720 
17.96Q 
25_. 8_50 
293 
18 
+500 
*
 
16 
8 
16 
16 
16 
8 
336 
32 
+500 
0 
32 
0 
0 
16 
16 
64· 
338 
29 
+500 
0 
64 
16 
8 
16 
8 
16 
296 
34 
+500 
*
 
16 
16 
16 
32 
32 
32 
co 
297 
41 
+500 
*
 
16 
8 
8 
8 
32 
32 
o
. 301 
59 
+500 
*
 
16 
8 
8 
32 
32 
32 
6 345 
30 
+500 
0 
16 
8 
16 
32 
16 
32 
~ 
350 
58 
+500 
0 
8 
4 
8 
16 
64 
32 
351 
22 
+500 
0 
8 
0 
16 
8 
32 
32 
M
ean: 
35.888 
+500.000 
0.000 
21 
.333 
7,556 
10.667 
19,556 
27.556 
31.111 
Standard E
rror: 
0.000 
5.810 
1.837 
1.885 
3.296 
5.515 
5.067 
T
otal M
ean: 
0.000 
24.000 
17.111 
23. 158 
32.632 
43.778 
69.500 
T
otal Standard E
rror: 
0.000 
4.242 
3.823 
4. 773 
6.855 
9.927 
15.844 
M
ann-W
hitney T
est: 
NS 
NS 
P=-.05 
P=-.05 
NS 
NS 
P=-.01 
C
ontrols 
340 
() 
0 
0 
0 
0 
0 
0 
341 
Cl 
0 
0 
0 
0 
0 
0 
353 
0 
0 
0 
0 
0 
0 
0 
-0 
_:::J-
.
.
_
_
, 
Figure 2: 
V
arying dilutions 
of hem
olysin, 
in the presence 
of a 
c
o
n
stan
t 
am
o
u
nt 
of co
m
plem
ent 
produces 
a 
"plateau" 
w
ith increasing dilutions (left to
 
right). 
The 
optim
al dilution (from 
the figure), is defined 
a
s the 
se
c
o
nd point in the plateau. 
The hem
olysin titratio
n
 preform
ed 
indicates the 
optim
al dilution to
 be 1:2000. 
Figure: 2 
H
em
olysin T
itration (The Plateau M
ethod) 
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Figure 3: 
"A, 
B, 
C, 
and D
are 
e
xperim
ently derived percentages 
of hem
olysis (= Y) 
c
o
n
v
e
rted 
to
 Y
/1-Y
 
and the latte·r plotted against 
c
o
rre
sponding m
illiter J!.o 
co
m
plem
ent dilution". 
The 
s
olid 
circle 
represents the m
idpoint indicating the intercept for finding m
illiter of comp.:. 
lem
ent dilution producing 50% hem
olysis. 
The figure 
show
s 
.26 
a
s being the intercept point, 
therefore: 
.26 
m
ls. 
of the 1/267 m
l. dilution 
=
 1 C
1H50 
u
nit 
(HEW R
eport, 
1965). 
Figure 3: 
Com
plem
ent T
itration (The D
eterm
ination of C
1H50 U
nits) 
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Figure 4: 
The 
m
ean 
re
ciprocal 
a
ntibody titers for group A
 is 
represented through the 
c
o
u
rse
 
of infection w
ith~
. pahangi. 
The 
standard 
e
rro
r is 
also 
represented for 
e
a
ch point plotted. 
Figure 4: 
G
roup ~ A
nim
als 
w
ith M
icrofilarem
ias L
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than 500.: 
M
ean R
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ntibody T
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Figure 5: 
The 
m
ean 
re
ciprocal 
a
ntibody titers for group B
is 
represented through the 
c
o
u
rse
 
of infection w
ith£· pahangi. 
The 
standard 
e
rro
r is 
also 
represented for 
e
a
ch point plotted. 
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Figure 6: 
The 
m
ean 
re
ciprocal 
a
ntibody titers for groups A
 and B
is 
represented c
o
m
paritively 
through the 
c
o
u
rse
 
of infection,w
ith B. 
pahangi. 
The 
standard 
e
rro
rs
 
a
re
 
also 
represented for 
e
a
ch group. 
-
Figure 6: 
M
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parison B
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Figure 7: 
The 
a
v
e
rage m
ean 
re
ciprocal 
a
ntibody titers for both groups A
 and B
is 
represented 
through the 
c
o
u
rse
 
of infection w
ith B. 
pahangi. 
The 
standard 
e
rro
r is also 
represented for 
e
a
ch point plotted. 
-
Figure 7: 
A
vera~~ of the M
eans for both G
roups A
 and B: 
M
ean R
eciprocal A
ntibody T
iters 
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(46) 
Discussion: 
Infection with~. pahangi in M· unguiculatus 
In the presented study, all 20 test animals developed patent, 
sustained infections. Seventeen test animals developed patent 
infections within, or shortly after 60 days, with the longest 
prepatent period being i18 days. These findings are consistent 
with those observed by Ash and Riley (1970). Microfilaria den-
sities vacillated throughout the course of infection in all an-
imals (Table J), with variable adult worm recoveries made at nec-
ropsy (Table 4). It must be noted that throughout the course of 
infection, approximately 50% of the animals sampled showed consist-
ently low microfilaria densities, regardless of 13 number innocula-
ted. These animals were separated from those of consistently high 
microfilarial densities to form 2 groups during testing to determine 
possible differences in antibody titers, if any. Worm recoveries 
differed slightly with respect to the ratio of males to females 
from those observed by Ash and Riley (1970) and Ash (1971). In the 
presented study, no clear ratio could be drawn from the total sample 
for the ratio of males to females as contrasted to Ash and Riley's 
findings of 2 females to 1 male ratio. However, this study is in 
agreement with total adult worm recovery being approximately 25% of 
the total infective larval dosage innoculated. The majority of the 
recovered worms were found in the testicles and their associated 
lymphatics, with significant numbers recovered in the heart and 
pulmonary arteries. These findings are also consistent with those 
(47) 
of Ash and Riley (1970). 
In general, this study substantiates the findings of previous re-
searchers, (Ash and Riley, 1970; Ash, 1971; McCall et. al. 1974; 
Ash and Schacher, 1970), with respect to areas of adult residence, 
worm burden percentages, and the beneficial use of the jird as an 
alternative host for B. pahangi. 
Hemolysin Titration: 
The amount of hemolysis produced by several dilutions of rabbit 
hemolysin in VBD buffer, in the presence of a constant amount of 
complement, was measured against a predetermined set of color stand-
ards. 
"When the Laboratory Bench Complement Fixation (LBCF; HEW Tech-
nical Report #74; 1965) titration results as read against color 
standards are plotted on arithmetic graph paper, the curve will 
show, if a sufficient concentration of hemolysin is present, that 
increasing amounts of hemolysin then produce no significantly 
greater percent hemolysis; therefore a plateau results". (HEW Tech-
nical Report #74, 1965) 
The plateau method employed in this study (represented in Figure 
2) was found to be very reliable for the determination of an optimal 
hemolysin concentration. The use of color standards as opposed to 
spectrophotometry proved more useful with ease of identification be-
tween individual tubes of h@molysates. With the color standards, 
percentages of hemolysis could be made within~ 5%. This margin 
of error, through several trials, was found to be insignificant. 
(48) 
By using color standards, much more time was saved. 
Several problems were encountered in the course of this tit~,,ation 
and the following complement titration. In the preliminary titrationi, 
percentages of hemolysis did not correspond with either the color 
standards or the standardized method. Lysates were found to be far 
too low, (percentage nemolysis) with minor adjustments producing 100% 
hemolysis. Through several trials, it was found that either the com-
plement stocks or hemolysin stocks were either too old or spoiled. New 
stocks were obtained from Grand Island Biological Co., and resultant 
titrations proved successful. All tests and titrations were performed 
several times over an extended period in order to demonstrate relia-
bility in testing and consistency in results. 
Complement Titration: 
In complement titration, a 50% hemolytic endpoint was employed to 
determine the potency of the stock complement. The 50% endpoint was 
defined as the volume of complement needed to lyse 50% of a sensi-
tized 2.8% SRBC suspension in the test system. In terms of the 50% 
endpoint, the potency of the stock complement was described in C1 H50 
units. One C'H50 unit was enough complement to lyse 50% of the sen-
sitized 2.8% SRBC suspension. The potency was determined to be 1:267, 
therefore 1.0 mls. of this dilution would lyse 50% of the cell suspen-
sion. The C1 H50 unit was derived from the reciprocal of the comple-
ment dilution which lysed 50% of the cell suspension (HEW Technical 
Report #74, 1965). 
Several trials were performed as previously described (Table 1), 
(49) 
with the potency of the stock at 267 C0 H50 . The complement fixation 
master test employed 5C'H50 units; therefore 1.3 mls. of the 1:267 
complement dilution equalled the 5c 0 H50 units needed. The lysates 
produced during titration were read against the color standards with 
the results graphically depicted (Figure J). This method produced 
accurate results with .Oo26 mls. of the 1:267 complement dilution 
being 1 C1 H50 unit. After the establishment of the stock complement 
potency, with the corresponding C1 H50 units, scaling dilutions to 
accommodate microtest conditions with "U" plates was easily accom-
plished. The resulatant dilution to achieve the 5C'H50 units in 
the "U" plate was a 1:9 of stock complement to VBD buffer. Therefore, 
50 microliters equalled the amount needed for the master test. 
As with the hemolysin titration, several titrations were performed 
in order to establish validity in testing. After the previous prob-
lems encountered with poor stocks, the addition of new stocks proved 
fruitful with relative ease in establishing the optimal dilutions 
necessary a 
Antigen Titration: 
In subsequent titrations, the key factor was in the reproduca-
bility of the results obtained in each test. Once this framework 
had been established, the antigen titration was performed. The 
titration of antigen was termed a "block" titration due to the vary-
ing dilutions of antigen and antisera used (Table 4). Varying dilu-
tions of antigen and standardized antisera (in VBD buffer), were 
titrated against each other. The concentration of antigen, unlike 
(50) 
that of complement, was not based on a "unit" system, rather by the 
optimal dilution which gave reproducable results. The optimal dilu-
tion of antigen was defined as the dilution which gave the highest 
complement fixing activity (without being anticomplementary), with 
the standard antisera and control sera. Anticomplementary dilutions 
of antigen were determined when less than 85% hemolysis resulted in 
the antigen-complement control wells containing 2.5 c•tt50 units 
(Table 4). The optimal dilution was found to be between 1:25 and 
1:50, without being anticomplementary (Table 4). Due to the scarcity 
of homologous antigen, the 1:50 dilution was chosen. Through repeated 
testing, the 1:50 dilution proved to be adequate for the purposes of 
this framework. 
The Complement Fixation Assay: 
In testing, 9J.5% of the test animals innoculated showed positive 
titers of curculating antibodies with complement fixing properties 
as high as 1:64, 6 weeks post-innoculation. Antibody titers were 
shown to vacillate during the course of infection (Table 5), with 
titers ranging from 1:4 to 1:256. The complement fixing antibody 
titers were expected to be lower than those observed in indirect 
hemagglutination as reported by Tanaka, 1969 and Tanaka et. al., 
1970, however, drew close correlation with~. pahangi in M. ungui-
culatus (Peak IHA titer; 1:512, Benjamin and Soulsby, 1976; Kowal-
ski, unpublished). Antibody titers were shown to increase up to 6 
weeks post infection with a marked decrease by J months post-inno-
culation. By the sixth month the amount of circulating complement 
(51) 
fixing antibody was shown to steadily increase starting a second peak 
12 months (Between 12 and 21 months) post-innoculation, to the time of 
necropsy. These finding are in partial agreement with those of Kowal-
ski (unpublished), using indirect hemagglutination. Kowalski found 
antibody appearing in the blood as early as J to 4 weeks post-innocu-
lation, with peak tit~rs showing 2 to J months post-innoculation. The 
circulating antibody would then drop off slightly at 3.5 to 4 months 
post-innoculation but remain steady thereafter. The presented study 
draws exception in that 0 circulating antibody was shown to steadily 
increase 6 months post-innoculation, also peak antibody titers were 
not demonstrated until late in the infection (Post 12 months). 
Tanaka (1969) tested cotton rats infected with Litomosoides using 
complement fixation with homologous antigen. Testing occured 11 weeks 
post-innoculation at a comparatively early stage of infection with 
good results. The reliability of complement fixation testing for long 
term filarial infections has been demonstrated (Tanaka, 1969; Tanaka 
et. ala, 1970). Several Litomosoides studies have been performed 
using complement fixation and homologous antigen with good results. 
However, to date, no studies have employed complement fixation with 
homologous~. pahangi antigen. 
Tanaka et. al. (1970) performed cross-reactions in complement fixa-
tion tests among filarial species. Brugia malayi and Wuchereria ban-
crofti were both tested for cross-reactivity with 1• carinii, D. 
immitus, and Setaria cervi. ~. bancrofti showed a fairly good re-
sponse with titers as high as 1:64, however, no response was seen with 
B. malayi for cross-reactivity with heterologous fi;larial antigens. 
(52) 
Other studies done using complement fixation with o. volvulus and 
homologous antigen showed low peak titers at 1:64. 
The scarcity of homologous antigen for Brugia .!?..12.£• has often hin-
dered immunologic studies, with homologous antigen for Wuchereria 
being almost impossible to obtain. 
Test Animals 
The test animals were qivided into 2 groups; group A, which showed 
consistantly low microfilaremias throughout the course of infection, 
and group B, with consistantly high microfilarial densities through-
out. Group A showed greater mean reciprocal antibody titers through-
out the course of testing, with steady increases each period. Group 
B displayed low mean titers throughout the sampling (as opposed to 
group A. Antibody titers peaked at 6 weeks post in..noculation fol-
lowed by a 3 fold decrease between the means 12 weeks post infection, 
with steady increases thereafter to necropsy where the mean titers 
were at their highest level. The Mann-Whitney "U" test, (Sokal and 
Rohlf 0 1969), showed significant statistical variations (between mean 
reciprocal antibody titers of groups A and B), during the third and 
sixth month with P values= ~.05, and at the twelth month, where the 
greatest despairity existed with P = L.01 (Table 5; Figure 6). Sig-
nificant statistical variations between the means using the Mann-
Whitney "U" test indicate a definite correlation between low micro-
filarial densities and high antibody titers. This correlation indi-
cates possible circulating antibody directed against microfilaria, 
gravid females, and/or metabolic wastes produced by the adult worms. 
(53) 
The data demonstrates, however, that the circulating antibody has 
specific complement fixing activity in the presence of homologous 
antigen. 
Both groups showed good stage specificity and reliability in 
complement fixation testing. Relatively high mean antibody titers 
were observed 6 weeks post innoculation, before patency and detec-
table microfilaremias. Antibody activity at this early stage of 
infection indicates an immunological response (humoral and possibly 
cellular) directed against immature and mature establishing adults. 
Much more data are needed to make any firm statements in regard to 
these postulations concerning the jirds immunological response. 
However, complement fixing circulating antibody directed against B. 
pahangi is present with definite correlations to microfilaremias. 
The homologous antigen used was a combination of adult male, female, 
and microfilariao Further tests with isolated specific antigen will 
be more effective for the further characterization of circulating 
antibody. 
The results of this study show good stage specificity in comple-
ment fixation testing with homologous antigen. The complement fixa-
tion test should be considered a valuable diagnostic tool for further 
filarial studies both with humans and experimental animals. 
(54) 
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